$6.13
al cierre: Oct 24 EDT
$6.15
0.020.33%
Pre-comercialización: 7:00 AM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Capricor Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 12
Estimación de BPA
$-0.540
Estimación de ingresos trimestrales
$1.25M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$13.39M
Analice el historial de beneficios de Capricor Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CAPR | Capricor Therapeutics | -$0.38 | -$0.54 | — | — | $2.26M | $1.25M | — | — | 11/12/2025 | |
CAPR | Capricor Therapeutics | -$0.35 | -$0.48 | -$0.57 | -18.75% | $3.97M | $1.62M | $0.00 | -100.00% | 08/11/2025 | |
CAPR | Capricor Therapeutics | -$0.31 | -$0.32 | -$0.53 | -65.62% | $4.91M | $3.16M | $0.00 | -100.00% | 05/13/2025 | |
CAPR | Capricor Therapeutics | -$0.02 | -$0.31 | -$0.16 | 48.39% | $12.09M | $3.20M | $11.13M | 247.84% | 03/19/2025 | |
CAPR | Capricor Therapeutics | -$0.25 | -$0.36 | -$0.38 | -5.56% | $6.18M | $3.57M | $2.26M | -36.64% | 11/13/2024 | |
CAPR | Capricor Therapeutics | -$0.29 | -$0.36 | -$0.35 | 2.78% | $3.92M | $3.66M | $3.97M | 8.50% | 08/07/2024 | |
CAPR | Capricor Therapeutics | -$0.31 | -$0.11 | -$0.31 | -181.82% | $2.99M | $9.70M | $4.91M | -49.41% | 05/13/2024 | |
CAPR | Capricor Therapeutics | -$0.31 | -$0.09 | -$0.02 | 77.78% | $959.90K | $10.60M | $12.09M | 14.04% | 02/29/2024 | |
CAPR | Capricor Therapeutics | -$0.26 | -$0.29 | -$0.25 | 13.79% | $1.59M | $2.11M | $6.18M | 193.13% | 11/14/2023 | |
CAPR | Capricor Therapeutics | -$0.29 | -$0.35 | -$0.29 | 17.14% | $0.00 | $1.50M | $3.92M | 161.13% | 08/07/2023 | |
CAPR | Capricor Therapeutics | -$0.32 | -$0.32 | -$0.31 | 3.12% | $0.00 | $500.00K | $2.99M | 497.40% | 05/11/2023 | |
CAPR | Capricor Therapeutics | -$0.26 | -$0.33 | -$0.31 | 6.06% | $0.00 | — | $959.90K | — | 03/15/2023 | |
CAPR | Capricor Therapeutics | -$0.17 | -$0.29 | -$0.26 | 10.34% | $0.00 | $210.00K | $1.59M | 658.10% | 11/10/2022 | |
CAPR | Capricor Therapeutics | -$0.22 | — | -$0.29 | — | $204.08K | — | $0.00 | — | 08/10/2022 | |
CAPR | Capricor Therapeutics | -$0.23 | — | -$0.32 | — | $40.82K | — | $0.00 | — | 05/10/2022 | |
CAPR | Capricor Therapeutics | -$0.21 | -$0.19 | -$0.26 | -36.84% | $57.83K | — | $0.00 | — | 03/10/2022 | |
CAPR | Capricor Therapeutics | -$0.20 | -$0.22 | -$0.17 | 22.73% | $16.86K | $210.00K | $0.00 | -100.00% | 11/09/2021 | |
CAPR | Capricor Therapeutics | -$0.23 | -$0.23 | -$0.22 | 4.35% | $49.86K | $210.00K | $204.08K | -2.82% | 08/12/2021 | |
CAPR | Capricor Therapeutics | -$0.30 | — | -$0.23 | — | $185.69K | — | $40.82K | — | 05/13/2021 | |
CAPR | Capricor Therapeutics | -$0.34 | — | -$0.21 | — | $222.10K | $210.00K | $57.83K | -72.46% | 03/11/2021 | |
CAPR | Capricor Therapeutics | -$0.43 | -$0.37 | -$0.20 | 45.95% | $142.07K | $210.00K | $16.86K | -91.97% | 11/12/2020 |
Capricor Therapeutics (CAPR) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $-0.57 | $-0.48 | -18.8 % |
| Q1 | 2025-05-13 | $-0.53 | $-0.32 | -65.6 % |
| Q4 | 2025-03-19 | $-0.16 | $-0.31 | 48.4 % |
| Q3 | 2024-11-13 | $-0.38 | $-0.36 | -5.56 % |
Capricor Therapeutics (CAPR) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $0 | $1.62M | -100.0 % |
| Q1 | 2025-05-13 | $0 | $3.16M | -100.0 % |
| Q4 | 2025-03-19 | $11.13M | $3.20M | 247.8 % |
| Q3 | 2024-11-13 | $2.26M | $3.57M | -36.6 % |
PREGUNTAS FRECUENTES
¿Cuándo Capricor Therapeutics (NASDAQ:CAPR) publicará los resultados?
Está previsto que Capricor Therapeutics (CAPR) presente resultados el noviembre 12, 2025. Los últimos resultados se publicaron el agosto 11, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Capricor Therapeutics (NASDAQ:CAPR)?
El BPA real fue de $-0.57, que no alcanzó la estimación de $-0.48.
¿Cuáles fueron los ingresos de Capricor Therapeutics (NASDAQ:CAPR)?
Los ingresos reales fueron $0K, que no alcanzó la estimación de $1.6M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.